Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50 Academic Article uri icon

Overview

MeSH Major

  • Carcinoma
  • Early Detection of Cancer
  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • A single PSA at or before age 50 predicts advanced prostate cancer diagnosed up to 30 years later. Use of early PSA to stratify risk would allow a large group of low-risk men to be screened less often but increase frequency of testing on a more limited number of high-risk men. This is likely to improve the ratio of benefit to harm for screening.

publication date

  • March 15, 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3412541

Digital Object Identifier (DOI)

  • 10.1002/cncr.25568

PubMed ID

  • 20960520

Additional Document Info

start page

  • 1210

end page

  • 9

volume

  • 117

number

  • 6